data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
GlycoMimetics
(NASDAQ:GLYC)
$0.6043
0.0493[8.88%]
At close: Jul 6
$0.6298
0.0255[4.22%]
After Hours: 4:21PM EDT
Day High/Low0.55 - 0.66
52 Week High/Low0.51 - 2.5
Open / Close0.55 / 0.6
Float / Outstanding32.8M / 52.4M
Vol / Avg.147.2K / 182.2K
Mkt Cap31.7M
P/E-
50d Avg. Price0.65
Div / Yield-
Payout Ratio-
EPS-0.28
Total Float32.8M

GlycoMimetics (NASDAQ:GLYC), Quotes and News Summary

GlycoMimetics (NASDAQ: GLYC)

Day High/Low0.55 - 0.66
52 Week High/Low0.51 - 2.5
Open / Close0.55 / 0.6
Float / Outstanding32.8M / 52.4M
Vol / Avg.147.2K / 182.2K
Mkt Cap31.7M
P/E-
50d Avg. Price0.65
Div / Yield-
Payout Ratio-
EPS-0.28
Total Float32.8M
Benzinga - Jun 3, 2022, 4:03PM
Benzinga - Apr 28, 2022, 7:34AM
Benzinga - Mar 3, 2022, 7:39AM
Benzinga - Dec 14, 2021, 7:36AM
Benzinga - Dec 13, 2021, 9:36AM
Benzinga - Dec 6, 2021, 9:20AM
Benzinga - Nov 23, 2021, 4:31PM
Benzinga - Nov 15, 2021, 7:04AM
Benzinga - Nov 12, 2021, 5:40AM
Benzinga - Nov 11, 2021, 9:07AM
Benzinga - Nov 2, 2021, 7:38AM
Benzinga - Sep 27, 2021, 10:01AM
Benzinga - Sep 27, 2021, 9:24AM
Benzinga - Sep 24, 2021, 6:57AM
Benzinga - Sep 23, 2021, 4:12PM
Sector: Health Care.Industry: Biotechnology
GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.310-0.280 0.0300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

GlycoMimetics Questions & Answers

Q
How do I buy GlycoMimetics (GLYC) stock?
A

You can purchase shares of GlycoMimetics (NASDAQ: GLYC) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are GlycoMimetics's (GLYC) competitors?
Q
What is the target price for GlycoMimetics (GLYC) stock?
A

The latest price target for GlycoMimetics (NASDAQ: GLYC) was reported by Jefferies on Friday, November 12, 2021. The analyst firm set a price target for 4.00 expecting GLYC to rise to within 12 months (a possible 561.92% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for GlycoMimetics (GLYC)?
A

The stock price for GlycoMimetics (NASDAQ: GLYC) is $0.6043 last updated July 6, 2022, 8:00 PM UTC.

Q
Does GlycoMimetics (GLYC) pay a dividend?
A

There are no upcoming dividends for GlycoMimetics.

Q
When is GlycoMimetics (NASDAQ:GLYC) reporting earnings?
A

GlycoMimetics’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is GlycoMimetics (GLYC) going to split?
A

There is no upcoming split for GlycoMimetics.

Q
What sector and industry does GlycoMimetics (GLYC) operate in?
A

GlycoMimetics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.